Zantac hit the US market as a prescription drug in 1983 before transforming into an over-the-counter heartburn treatment in 1995. GSK and Warner Lambert developed it as part of a joint venture, ...

But the lot number and the manufacturer's name may be missing from the label entirely. In that case, your drugstore can provide the information. My drug has been recalled. ... too. “Consumers can ...

GSK plc's stock downgraded from “Buy” to “Hold” due to litigation risks, disappointing RSV vaccine sales, and competitive pressures in the HIV space. Despite strong cash flow, GSK's Zantac ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

Recent surprise decisions have upended plaintiffs’ expectations on the toxic tort front. In Delaware, the top court is rehearing the trial court’s evidentiary ruling admitting plaintiffs’ experts’ ...

News Lawsuit Linking Zantac to Cancer Diagnoses Survives Fight Over Jurisdiction Waterbury Superior Court Judge W. Glen Pierson ruled that defendants, having registered to do business in ...

A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer. The ...

Illinois resident Angela Valadez had alleged that her cancer was a result of taking over-the-counter Zantac and generic versions of it from 1995 to 2014.

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar ...

Zantac pharma exec calls heartburn drug safe and effective during testimony against cancer claims The executive, a medical doctor who oversaw drug safety for decades at drugmaker GSK, repeatedly ...